NCT01391377View on ClinicalTrials.gov

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Niacin/Laropiprant combination

Niacin 1g / Laropiprant 20mg for 4 weeks followed by Niacin 2g / Laropiprant 20mg for 4 weeks

DRUG

Sugar pill

Placebo

Trial Locations (1)

3004

Baker IDI Heart and diabetes research institute, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

lead

Bayside Health

OTHER_GOV